Insulet Free Cash Flow (FCF) History (PODD)
Insulet reported $377.7M in free cash flow for fiscal 2025, an increase of 23.71% from the previous fiscal year, with a free cash flow margin of 13.95%.
View full Insulet company overviewInsulet free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $377.7M | $72.4M | +23.71% | +13.95% |
| 2024 | 2024-12-31 | $305.3M | $235.2M | +335.52% | +14.74% |
| 2023 | 2023-12-31 | $70.1M | $74.0M | — | +4.13% |
| 2022 | 2022-12-31 | −$3.9M | $176.1M | — | −0.37% |
| 2021 | 2021-12-31 | −$180.0M | −$135.0M | — | −17.30% |
| 2020 | 2020-12-31 | −$45.0M | $20.3M | — | −4.98% |
| 2019 | 2019-12-31 | −$65.3M | $56.2M | — | −8.85% |
| 2018 | 2018-12-31 | −$121.5M | −$89.0M | — | −21.55% |
| 2017 | 2017-12-31 | −$32.5M | −$26.3M | — | −7.01% |
| 2016 | 2016-12-31 | −$6.2M | $17.0M | — | −1.69% |
| 2015 | 2015-12-31 | −$23.2M | −$20.6M | — | −8.78% |
| 2014 | 2014-12-31 | −$2.6M | $1.4M | — | −1.11% |
| 2013 | 2013-12-31 | −$4.0M | $36.1M | — | −1.60% |
| 2012 | 2012-12-31 | −$40.0M | −$3.5M | — | −18.95% |
| 2011 | 2011-12-31 | −$36.6M | $5.6M | — | −24.02% |
| 2010 | 2010-12-31 | −$42.2M | $10.3M | — | −43.49% |
| 2009 | 2009-12-31 | −$52.5M | — | — | −79.45% |
Insulet quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $55.9M | −$122.0M | −68.58% | +6.97% |
| Q1 2026 | 2026-03-31 | $89.5M | $38.0M | +73.79% | +11.75% |
| Q4 2025 | 2025-12-31 | $48.2M | −$45.7M | −48.67% | +6.15% |
| Q3 2025 | 2025-09-30 | $100.1M | $18.5M | +22.67% | +14.17% |
| Q2 2025 | 2025-06-30 | $177.9M | $113.6M | +176.67% | +27.41% |
| Q1 2025 | 2025-03-31 | $51.5M | −$14.0M | −21.37% | +9.05% |
| Q4 2024 | 2024-12-31 | $93.9M | $78.0M | +490.57% | +15.72% |
| Q3 2024 | 2024-09-30 | $81.6M | $45.7M | +127.30% | +15.00% |
| Q2 2024 | 2024-06-30 | $64.3M | $36.0M | +127.21% | +13.16% |
| Q1 2024 | 2024-03-31 | $65.5M | $75.5M | — | +14.83% |
| Q4 2023 | 2023-12-31 | $15.9M | $29.6M | — | +2.62% |
| Q3 2023 | 2023-09-30 | $35.9M | $10.3M | +40.23% | +8.30% |
| Q2 2023 | 2023-06-30 | $28.3M | $17.6M | +164.49% | +7.14% |
| Q1 2023 | 2023-03-31 | −$10.0M | $16.5M | — | −3.83% |
| Q4 2022 | 2022-12-31 | −$13.7M | $43.6M | — | −4.85% |
| Q3 2022 | 2022-09-30 | $25.6M | $78.7M | — | +9.08% |
| Q2 2022 | 2022-06-30 | $10.7M | $12.3M | — | +4.39% |
| Q1 2022 | 2022-03-31 | −$26.5M | $41.5M | — | −10.73% |
| Q4 2021 | 2021-12-31 | −$57.3M | −$23.5M | — | −21.27% |
| Q3 2021 | 2021-09-30 | −$53.1M | −$70.8M | — | −20.28% |
| Q2 2021 | 2021-06-30 | −$1.6M | −$3.2M | — | −0.62% |
| Q1 2021 | 2021-03-31 | −$68.0M | −$37.5M | — | −27.25% |
| Q4 2020 | 2020-12-31 | −$33.8M | −$31.6M | — | −13.73% |
| Q3 2020 | 2020-09-30 | $17.7M | $9.3M | +110.71% | +7.56% |
| Q2 2020 | 2020-06-30 | $1.6M | $35.2M | — | +0.71% |
| Q1 2020 | 2020-03-31 | −$30.5M | $7.4M | — | −15.40% |
| Q4 2019 | 2019-12-31 | −$2.2M | −$95,000 | — | −1.05% |
| Q3 2019 | 2019-09-30 | $8.4M | $29.7M | — | +4.37% |
| Q2 2019 | 2019-06-30 | −$33.6M | $24.9M | — | −18.97% |
| Q1 2019 | 2019-03-31 | −$37.9M | $1.7M | — | −23.75% |
| Q4 2018 | 2018-12-31 | −$2.1M | $2.0M | — | −1.28% |
| Q3 2018 | 2018-09-30 | −$21.3M | −$35.8M | — | −14.08% |
| Q2 2018 | 2018-06-30 | −$58.5M | −$63.1M | — | −47.07% |
| Q1 2018 | 2018-03-31 | −$39.6M | $7.9M | — | −32.08% |
| Q4 2017 | 2017-12-31 | −$4.1M | −$21.3M | — | −3.14% |
| Q3 2017 | 2017-09-30 | $14.5M | $25.2M | — | +11.93% |
| Q2 2017 | 2017-06-30 | $4.6M | $3.6M | +388.78% | +4.17% |
| Q1 2017 | 2017-03-31 | −$47.5M | −$33.8M | — | −46.71% |
| Q4 2016 | 2016-12-31 | $17.2M | $39.2M | — | +16.57% |
| Q3 2016 | 2016-09-30 | −$10.6M | −$16.8M | — | −11.20% |
| Q2 2016 | 2016-06-30 | $936,000 | $406,000 | +76.60% | +1.07% |
| Q1 2016 | 2016-03-31 | −$13.7M | −$5.8M | — | −16.84% |
| Q4 2015 | 2015-12-31 | −$22.1M | −$24.1M | — | −26.34% |
| Q3 2015 | 2015-09-30 | $6.2M | $4.5M | +262.95% | +8.71% |
| Q2 2015 | 2015-06-30 | $530,000 | $3.6M | — | +0.88% |
| Q1 2015 | 2015-03-31 | −$7.8M | −$4.7M | — | −16.27% |
| Q4 2014 | 2014-12-31 | $2.0M | $8.3M | — | +13.02% |
| Q3 2014 | 2014-09-30 | $1.7M | −$158,000 | −8.44% | +2.29% |
| Q2 2014 | 2014-06-30 | −$3.1M | −$5.8M | — | −4.28% |
| Q1 2014 | 2014-03-31 | −$3.2M | −$905,000 | — | −4.59% |
| Q4 2013 | 2013-12-31 | −$6.3M | $1.3M | — | −9.20% |
| Q3 2013 | 2013-09-30 | $1.9M | $10.0M | — | +3.06% |
| Q2 2013 | 2013-06-30 | $2.7M | $16.4M | — | +4.57% |
| Q1 2013 | 2013-03-31 | −$2.3M | $8.3M | — | −3.96% |
| Q4 2012 | 2012-12-31 | −$7.6M | $2.3M | — | −13.23% |
| Q3 2012 | 2012-09-30 | −$8.1M | −$4.0M | — | −14.86% |
| Q2 2012 | 2012-06-30 | −$13.7M | −$1.9M | — | −26.77% |
| Q1 2012 | 2012-03-31 | −$10.6M | $161,000 | — | −22.20% |
| Q4 2011 | 2011-12-31 | −$9.9M | $4.6M | — | −21.07% |
| Q3 2011 | 2011-09-30 | −$4.1M | — | — | −9.23% |
| Q2 2011 | 2011-06-30 | −$11.7M | — | — | −36.46% |
| Q1 2011 | 2011-03-31 | −$10.8M | — | — | −38.09% |
| Q3 2010 | 2010-09-30 | −$14.5M | — | — | −57.00% |
Insulet free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$45.0M to $377.7M, a net increase of $422.7M. Insulet's latest reported quarter, Q2 2026, generated $55.9M in free cash flow, a decrease of 68.58% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Insulet filings at SEC.gov ↗